Abstract
ALTHOUGH it was established by Harington and Salter (1930) that thyroxine naturally occurs in the thyroid in the optically active levo form, there is still considerable uncertainty as to the relative potency of pure 1-thyroxine and the racemic thyroxine that until recently has been the only form readily available for animal experimentation and clinical use. Using compounds prepared by Harington (1928) Gaddum reported that, as tested by the stimulation of tadpole metamorphosis (1927) and rat metabolism (1929-30), 1-thyroxine showed about three times the potency of the d- form. Upon testing the same compounds in human myxedema, Salter, Lerman and Means (1935) found no difference in activity. On the other hand Foster, Palmer and Leland (1936) reported that 1-thyroxine obtained by the enzymatic hydrolysis of thyroid substance exerted twice the effect of a racemic mixture as judged by its calorigenic effect in guinea pigs, and thus inferred that the d- compound is devoid of activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
